Home/Filings/4/0001209191-18-037316
4//SEC Filing

Shanafelt Armen 4

Accession 0001209191-18-037316

CIK 0001377121other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 6:50 PM ET

Size

5.8 KB

Accession

0001209191-18-037316

Insider Transaction Report

Form 4
Period: 2018-05-29
Shanafelt Armen
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2018-05-29+12,00012,000 total
    Exercise: $6.98Exp: 2028-05-28Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan).

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1
  • filerCIK 0001656151

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:50 PM ET
Size
5.8 KB